Imagine a world where a simple blood test could reveal hidden risks to your health long before symptoms appear, allowing for preventive measures that could save lives, and this is no longer a distant dream but a reality through a groundbreaking program offered by Parkview Health. Known as DNA
In a world where complex diseases like cancer and neurodegenerative disorders continue to challenge medical science, a transformative approach is emerging through artificial intelligence (AI). Imagine a tool so precise that it can predict the exact genetic targets needed to reverse a diseased
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in cutting-edge technology and innovation within the industry. Today, we’re diving into a groundbreaking discovery about extrachromosomal DNA, or ecDNA, and
The world of drug discovery is witnessing a seismic shift as researchers and institutions move away from traditional animal models toward innovative human-based in vitro systems, driven by a pressing need to address the staggering failure rate of drug candidates in clinical trials, which exceeds
In a landscape where mesothelioma, a devastating cancer often linked to asbestos exposure, has long been synonymous with poor survival rates and limited treatment options, a new clinical trial offers a glimmer of hope that could redefine patient outcomes. Conducted by experts at the Johns Hopkins
Imagine a scenario where patients with advanced non-small cell lung cancer (NSCLC), particularly those with EGFR mutations who have exhausted standard treatments, face limited options for managing their disease, and with progression after tyrosine kinase inhibitor (TKI) therapy often signaling a
